Finance

Lists
RMTI:NASDAQ
Rockwell Medical Ord Shs
7,89 $
-1,62%
(-0,13) 1D
9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMTI...
Open
7,97 $
High
8,02 $
Low
7,89 $
Mkt. cap
31,80 մլն
Avg. vol.
22,53 հզր
Volume
8,00 հզր
52-wk high
12,90 $
52-wk low
4,88 $
EPS
-1,37 $
Beta
1,63
Shares outstanding
4,03 մլն
No. of employees
157
Open
7,97 $
High
8,02 $
Low
7,89 $
Mkt. cap
31,80 մլն
Avg. vol.
22,53 հզր
Volume
8,00 հզր
52-wk high
12,90 $
52-wk low
4,88 $
EPS
-1,37 $
Beta
1,63
Shares outstanding
4,03 մլն
No. of employees
157
News stories
From web sources and news partners
Profile
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease. The company's primary customers are dialysis providers. Wikipedia
About Rockwell Medical Ord Shs
CEO-
Employees157
Founded1996
HeadquartersWixom, Միչիգան, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to RMTI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RMTI in the last 3 months.
Highest
Current 7,89 $
20,00 $ (+153,49%)
Average
20,00 $ (+153,49%)
Lowest
20,00 $ (+153,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
20,00 $
+153,5%
09/11/2026
Anthony Vendetti
Maxim Group
Buy
Maintained
20,00 $
+153,5%
08/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
15,93 մլն
18,35 մլն
17,34 մլն
17,78 մլն
Cost of goods sold
13,66 մլն
14,47 մլն
14,44 մլն
14,54 մլն
Cost of revenue
13,66 մլն
14,47 մլն
14,44 մլն
14,54 մլն
Research and development expenses
-
-
-
40,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,86 մլն
4,28 մլն
4,38 մլն
4,26 մլն
Operating expense
3,86 մլն
4,28 մլն
4,38 մլն
4,30 մլն
Total operating expenses
17,51 մլն
18,74 մլն
18,82 մլն
18,84 մլն
Operating income
-1,58 մլն
-398,00 հզր
-1,48 մլն
-1,06 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-1,75 մլն
-554,00 հզր
-1,60 մլն
-1,17 մլն
EBT excluding unusual items
-1,81 մլն
-640,00 հզր
-1,72 մլն
-1,30 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,75 մլն
-554,00 հզր
-1,60 մլն
-1,17 մլն
Net profit margin
-11,01%
-3,02%
-9,26%
-6,59%
Earnings per share
-
-
-
-
Interest and investment income
55,00 հզր
44,00 հզր
37,00 հզր
40,00 հզր
Interest expense
-285,00 հզր
-286,00 հզր
-282,00 հզր
-281,00 հզր
Net interest expenses
-230,00 հզր
-242,00 հզր
-245,00 հզր
-241,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,04 մլն
148,00 հզր
-969,00 հզր
-569,00 հզր
Gain or loss from assets sale
-1,00 հզր
1,00 հզր
178,00 հզր
-32,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps